UBS Initiates Coverage On Pediatrix Medical Group With Neutral Rating, Announces Price Target of $9.5
UBS Initiates Coverage On Pediatrix Medical Group With Neutral Rating, Announces Price Target of $9.5
瑞銀以中性評級啓動對Pediatrix醫療集團的保險,宣佈目標股價爲9.5美元
UBS analyst A.J. Rice initiates coverage on Pediatrix Medical Group (NYSE:MD) with a Neutral rating and announces Price Target of $9.5.
瑞銀分析師A.J. Rice以中性評級開始對Pediatrix Medical Group(紐約證券交易所代碼:MD)進行報道,並宣佈目標股價爲9.5美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。